About SinoBio Access
What SinoBio Access Is
SinoBio Access is an independent, evidence-centred platform that connects Chinese biomedical manufacturers with healthcare markets in Russia and India. Our role is to make manufacturer claims transparent, to classify the evidence behind those claims, and to give professional users the information they need to evaluate Chinese biomedical technologies for their own markets.
What SinoBio Access Is Not
SinoBio Access is not a distributor. We do not buy, stock, sell, or ship medical devices. We do not take possession of products and we do not handle commercial transactions.
SinoBio Access is not a medical device company. We do not design, manufacture, or register medical devices. We do not make clinical claims on behalf of manufacturers.
SinoBio Access is not a regulator. We do not grant registrations, certifications, or approvals. Regulatory status in each market is stated as "not verified" unless an official regulatory document has been independently confirmed.
Our Mission
The global biomedical market contains a widening gap between the manufacturing capacity of Chinese biomedical companies and the ability of clinicians and procurement teams in Russia and India to evaluate those technologies independently. Marketing materials, brochures, and verbal claims travel faster than verified data.
Our mission is to close that gap with evidence, not promotion. We collect manufacturer documents, label every claim with a verification status, publish the evidence transparently, and explain what remains unverified.
What We Do
- Evidence verification — We collect manufacturer-provided documents (instructions for use, technical specifications, brochures, certificates) and classify the evidence behind each claim using a transparent evidence-level system (A through U).
- Market access intelligence — For each target market (Russia and India), we document the local regulatory pathway, the registration status, and the local implementation gaps that a buyer would need to resolve.
- Professional user support — We provide structured evaluation checklists, regulatory question guides, and methodology articles so that laboratory directors, procurement teams, and clinicians can make informed decisions.
How We Label Claims
Every claim published on this platform carries one of the following statuses:
- Manufacturer-provided information — Provided directly by the manufacturer. Not independently verified.
- Supported by an external source — Backed by at least one external source such as a peer-reviewed study, regulator, or guideline.
- Document discrepancy identified — Two or more sources disagree. The discrepancy is documented and published.
- Pending verification — Verification is in progress; a definitive statement is not yet available.
- Local regulatory status not verified — The local regulatory status for this market has not been checked.
- Verified for the specified market — An official regulatory document for this market has been independently confirmed.
Markets We Serve
We currently support market-access evaluation for Russia and India. Each market has its own content, regulatory pathway, and local implementation context. Content is strictly isolated by market so that regulatory status and local guidance are never mixed between regions.
Who This Platform Is For
SinoBio Access is intended for professional users: laboratory directors, clinicians, procurement specialists, regulatory affairs professionals, and public health decision-makers. Medical device information on this platform is intended for healthcare professionals only and is not a substitute for professional clinical judgement.
Our Commitment
- We do not publish statements such as "FDA Approved", "WHO Approved", or "Available for purchase" without an independently confirmed source.
- We document conflicts between sources rather than hiding them.
- We default every regulatory status to "not verified" until an official document is confirmed.
- We separate manufacturer claims from independent evidence at all times.
For the full methodology behind our evidence classification, see How We Work. For the rules that govern claim labelling, see Evidence Policy.